Respokare® NIOSH N95 Respirator Mask 

Revolutionary patented design by Innonix, a company at the forefront of cutting edge innovation in personal protective equipment for over 19 years. Advanced antiviral technology not only blocks 95% of small (.3 micron) particles, but inactivates up to 99.9% within minutes.

FEATURES:

  • NIOSH APPROVED N95
  • NELSON LABS TESTED
  • U.S. PATENTED ANTIVIRAL TECH

NIOSH APPROVED N95

Subjected to rigorous testing, this mask blocks 95% of very small (0.3 micron) particles. FDA Approved. CDC approval #84A-7796.

NELSON LABS TESTED

Validation tests were conducted in compliance with GLP regulation. Approved according to 42 CFR Part 84.

U.S. PATENTED ANTIVIRAL TECH

Revolutionary Innonix design decreases the transmission of one (or more than one) human pathogen by antibacterial, anti-fungal, and antiviral activity.

THE TECHNOLOGY

Our patented multilayer, anti-viral technology has proven effective in the inactivation of 99.9% of flu viruses and other airborne health hazards.

INNER LAYER

Built of high quality, soft materials to ensure comfort during periods of long wear. Plus, water resistant for a final layer of protection.

FILTER LAYER

Effectively traps fine particles that make their way through the first two layers.

ANTIVIRAL LAYER

Copper and zinc ions within this layer cause structural rearrangement in the proteins, nucleic acids and lipids; inactivating and destroying…

OUTER LAYER

Traps contaminated droplets using a special hydrophilic plastic that increases the permeation of liquids.

WHAT DOES IT BLOCK?

Respokare® Anti-Viral Mask is highly effective against 18 common Seasonal & Pandemic Influenza Viruses, as well as
a wide range of other pathogens, bacteria and fungi.

THE
NUMBERS

Rigorous testing and years of R&D have deemed the Respokare® NIOSH N95 Respirator Mask highly effective against 18 common seasonal and pandemic influenza viruses.